All In Biotech

Free tool

FAERS Monitor: Praluent

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125559 or its brand name (Praluent, Alirocumab). Reports on generic versions are filed under their own applications.

Reports

25,752

Serious

6,952

27% of reports

Hospitalization

2,674

Death reported

511

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • myalgia1,710
  • injection site pain1,406
  • product dose omission1,363
  • muscle spasms1,209
  • arthralgia1,088
  • fatigue1,054
  • pain979
  • pain in extremity959
  • product dose omission issue926
  • injection site bruising905
  • diarrhoea833
  • headache823
  • influenza like illness811
  • device issue791
  • injection site haemorrhage752

Reports by year received

View as table
YearReports
20081
2015297
20162,738
20173,158
20184,179
20194,511
20202,093
20211,741
20221,662
20231,583
20241,364
20251,110
20261,315

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,407 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product dose omissionSignal1,36317.416.520,671
injection site bruisingSignal9059.48.86,698
myalgiaSignal1,7108.37.910,930
influenza like illnessSignal8118.17.65,025
injection site haemorrhageSignal7527.87.24,392
device issueSignal7917.36.84,243
muscle spasmsSignal1,2095.45.14,351
injection site painSignal1,4063.83.62,870
pain in extremitySignal9592.72.51,006
product dose omission issueSignal9262.62.4902
arthralgiaSignal1,0882.12.0671
pain9791.31.270
fatigue1,0541.11.011
headache8231.11.04
diarrhoea8331.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.